BioAtla Investor Presentation Deck

Leadership Team Jay Short, Ph.D. Chairman, CEO and Cofounder STRATAGENE DIVERSA HARNESSING THE POWER OF ENZYMES Eric Sievers, M.D. Chief Medical Officer OSeattleGenetics ZYMOGENETICS A Bristol-Myers Squibb Company. bicatla life technologies FRED HUTCH CURES START HERE" Scott Smith, M.S., M.B.A. President Celgene BIOVAIL SYNTHETIC GENOMICS PHARMACIA Cathy Chang, Ph.D. Sr. VP, Research & Development DIVERSA HARNESSING THE POWER OF ENZYMES 1STRATAGENE Richard Waldron, M.B.A. Chief Financial Officer INTREXON GeneMedicine, Inc. COWEN AND COMPANY William Boyle, Ph.D. Sr. Research Fellow AnaptysBio AMGEN salk Where cures begin. Philippe Martin, M.S., M.B.A. Chief of Clinical Dev & Operations Schering-Plough Celgene Aventis Aventis Monica Sullivan Sr. VP, Intellectual Property & Contracts STRATAGENE DIVERSA HARNESSING THE POWER OF ENZYMES CapalP Sheri Lydick Sr. VP, Commercial Strategy Celgenel Bristol Myers Squibb™ ALTANA Susie Melody Sr. VP, Human Resources senomyx Biogen BCG BioAtla | Overview 4

View entire presentation